1. Home
  2. ILMN vs ALC Comparison

ILMN vs ALC Comparison

Compare ILMN & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$211.37

Market Cap

32.3B

Sector

Health Care

ML Signal

HOLD

Logo Alcon Inc.

ALC

Alcon Inc.

HOLD

Current Price

$69.39

Market Cap

34.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ILMN
ALC
Founded
1998
1945
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Medical Specialities
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3B
34.1B
IPO Year
2000
2002

Fundamental Metrics

Financial Performance
Metric
ILMN
ALC
Price
$211.37
$69.39
Analyst Decision
Hold
Buy
Analyst Count
17
12
Target Price
$124.24
$89.38
AVG Volume (30 Days)
1.6M
1.4M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
0.25%
EPS Growth
170.87
N/A
EPS
2.22
N/A
Revenue
$4,343,000,000.00
N/A
Revenue This Year
$6.47
$7.99
Revenue Next Year
$5.58
$6.38
P/E Ratio
$95.07
$38.31
Revenue Growth
N/A
N/A
52 Week Low
$88.00
$61.84
52 Week High
$231.81
$87.64

Technical Indicators

Market Signals
Indicator
ILMN
ALC
Relative Strength Index (RSI) 54.52 38.66
Support Level $182.76 $66.08
Resistance Level $231.81 $69.75
Average True Range (ATR) 9.45 1.09
MACD -0.77 -0.53
Stochastic Oscillator 51.24 7.62

Price Performance

Historical Comparison
ILMN
ALC

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: